These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma. Singh S; Abu-Zaid A; Jin H; Fang J; Wu Q; Wang T; Feng H; Quarni W; Shao Y; Maxham L; Abdolvahabi A; Yun MK; Vaithiyalingam S; Tan H; Bowling J; Honnell V; Young B; Guo Y; Bajpai R; Pruett-Miller SM; Grosveld GC; Hatley M; Xu B; Fan Y; Wu G; Chen EY; Chen T; Lewis PW; Rankovic Z; Li Y; Murphy AJ; Easton J; Peng J; Chen X; Wang R; White SW; Davidoff AM; Yang J Sci Transl Med; 2022 Jul; 14(653):eabq2096. PubMed ID: 35857643 [TBL] [Abstract][Full Text] [Related]
24. The PAX-FOXO1s trigger fast trans-differentiation of chick embryonic neural cells into alveolar rhabdomyosarcoma with tissue invasive properties limited by S phase entry inhibition. Gonzalez Curto G; Der Vartanian A; Frarma YE; Manceau L; Baldi L; Prisco S; Elarouci N; Causeret F; Korenkov D; Rigolet M; Aurade F; De Reynies A; Contremoulins V; Relaix F; Faklaris O; Briscoe J; Gilardi-Hebenstreit P; Ribes V PLoS Genet; 2020 Nov; 16(11):e1009164. PubMed ID: 33175861 [TBL] [Abstract][Full Text] [Related]
25. [Expression of fusion gene PAX3/PAX7-FKHR and chromosomal aberration in rhabdomyosarcoma]. Gao H; Ou YL; Zhang KR; Zhang ZB; Wang WL Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):42-7. PubMed ID: 17285543 [TBL] [Abstract][Full Text] [Related]
26. Detection and clinical significance of bone marrow involvement in patients with rhabdomyosarcoma. Krsková L; Mrhalová M; Hilská I; Sumerauer D; Drahokoupilová E; Múdry P; Kodet R Virchows Arch; 2010 May; 456(5):463-72. PubMed ID: 20405298 [TBL] [Abstract][Full Text] [Related]
27. Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: a comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions. Collins MH; Zhao H; Womer RB; Barr FG Med Pediatr Oncol; 2001 Aug; 37(2):83-9. PubMed ID: 11496344 [TBL] [Abstract][Full Text] [Related]
28. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. Williamson D; Missiaglia E; de Reyniès A; Pierron G; Thuille B; Palenzuela G; Thway K; Orbach D; Laé M; Fréneaux P; Pritchard-Jones K; Oberlin O; Shipley J; Delattre O J Clin Oncol; 2010 May; 28(13):2151-8. PubMed ID: 20351326 [TBL] [Abstract][Full Text] [Related]
29. Cyclin-dependent kinase 4 phosphorylates and positively regulates PAX3-FOXO1 in human alveolar rhabdomyosarcoma cells. Liu L; Wu J; Ong SS; Chen T PLoS One; 2013; 8(2):e58193. PubMed ID: 23469153 [TBL] [Abstract][Full Text] [Related]
30. Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations. Ren YX; Finckenstein FG; Abdueva DA; Shahbazian V; Chung B; Weinberg KI; Triche TJ; Shimada H; Anderson MJ Cancer Res; 2008 Aug; 68(16):6587-97. PubMed ID: 18701482 [TBL] [Abstract][Full Text] [Related]
31. Secreted Frizzled-Related Protein 3 (SFRP3) Is Required for Tumorigenesis of PAX3-FOXO1-Positive Alveolar Rhabdomyosarcoma. Kephart JJ; Tiller RG; Crose LE; Slemmons KK; Chen PH; Hinson AR; Bentley RC; Chi JT; Linardic CM Clin Cancer Res; 2015 Nov; 21(21):4868-80. PubMed ID: 26071485 [TBL] [Abstract][Full Text] [Related]
32. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. Kelly KM; Womer RB; Sorensen PH; Xiong QB; Barr FG J Clin Oncol; 1997 May; 15(5):1831-6. PubMed ID: 9164192 [TBL] [Abstract][Full Text] [Related]
33. Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells. Calhabeu F; Hayashi S; Morgan JE; Relaix F; Zammit PS Oncogene; 2013 Jan; 32(5):651-62. PubMed ID: 22710712 [TBL] [Abstract][Full Text] [Related]
34. Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Rudzinski ER; Teot LA; Anderson JR; Moore J; Bridge JA; Barr FG; Gastier-Foster JM; Skapek SX; Hawkins DS; Parham DM Am J Clin Pathol; 2013 Jul; 140(1):82-90. PubMed ID: 23765537 [TBL] [Abstract][Full Text] [Related]
35. Rhabdomyosarcoma: value of myogenin expression analysis and molecular testing in diagnosing the alveolar subtype: an analysis of 109 paraffin-embedded specimens. Hostein I; Andraud-Fregeville M; Guillou L; Terrier-Lacombe MJ; Deminière C; Ranchère D; Lussan C; Longavenne E; Bui NB; Delattre O; Coindre JM Cancer; 2004 Dec; 101(12):2817-24. PubMed ID: 15536621 [TBL] [Abstract][Full Text] [Related]
36. PAX3-NCOA1 alveolar rhabdomyosarcoma of the tongue: A rare entity with challenging diagnosis and management. Di Carlo D; Chargari C; Scoazec JY; Cotteret S; Felix A; Moalla S; Temam S; Minard-Colin V Pediatr Blood Cancer; 2021 Nov; 68(11):e29288. PubMed ID: 34424607 [TBL] [Abstract][Full Text] [Related]
37. Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. Barr FG; Duan F; Smith LM; Gustafson D; Pitts M; Hammond S; Gastier-Foster JM Genes Chromosomes Cancer; 2009 Aug; 48(8):661-72. PubMed ID: 19422036 [TBL] [Abstract][Full Text] [Related]
38. Loss of MST/Hippo Signaling in a Genetically Engineered Mouse Model of Fusion-Positive Rhabdomyosarcoma Accelerates Tumorigenesis. Oristian KM; Crose LES; Kuprasertkul N; Bentley RC; Lin YT; Williams N; Kirsch DG; Linardic CM Cancer Res; 2018 Oct; 78(19):5513-5520. PubMed ID: 30093562 [TBL] [Abstract][Full Text] [Related]
39. Examination of gene fusion status in archival samples of alveolar rhabdomyosarcoma entered on the Intergroup Rhabdomyosarcoma Study-III trial: a report from the Children's Oncology Group. Barr FG; Smith LM; Lynch JC; Strzelecki D; Parham DM; Qualman SJ; Breitfeld PP J Mol Diagn; 2006 May; 8(2):202-8. PubMed ID: 16645206 [TBL] [Abstract][Full Text] [Related]
40. Investigation of PAX3/7-FKHR fusion genes and IGF2 gene expression in rhabdomyosarcoma tumors. de Souza RR; Oliveira ID; Caran EM; Alves MT; Abib S; Toledo SR Growth Horm IGF Res; 2012 Dec; 22(6):245-9. PubMed ID: 23079386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]